Zobrazeno 1 - 10
of 119
pro vyhledávání: '"W J, Jusko"'
Publikováno v:
Pediatric Transplantation. 3:126-130
The area under the time-plasma concentration curve (AUC) was measured for prednisolone (the major active metabolite of prednisone) after ingestion of 15 mg of prednisone (phase 1) and again after 3 d of oral diltiazem (180 mg/d) followed by the same
Autor:
D E, Mager, W J, Jusko
Publikováno v:
Journal of pharmacokinetics and pharmacodynamics. 28(6)
Drugs that bind with high affinity and to a significant extent (relative to dose) to a pharmacologic target such as an enzyme, receptor, or transporter may exhibit nonlinear pharmacokinetic (PK) behavior. Processes such as receptor-mediated endocytos
Publikováno v:
Journal of clinical pharmacology. 38(12)
A double-blind, placebo-controlled, parallel-group, ascending, multiple-dose study was completed in 45 healthy male volunteers to assess the maximum tolerated dose, pharmacokinetics, and pharmacodynamics of BMS-187745, a squalene synthase inhibitor,
Autor:
J V, Gobburu, W J, Jusko
Publikováno v:
Advanced drug delivery reviews. 46(1-3)
The role of drug delivery in controlling indirect pharmacodynamic responses was assessed via computer simulations and literature review. Simulations of responses related to basic indirect response mechanisms were performed for various drug input rate
Autor:
W, Krzyzanski, W J, Jusko
Publikováno v:
Journal of pharmacokinetics and pharmacodynamics. 28(1)
Basic indirect response models where drug alters the production (kin) of the response variable (R) based on the Hill function previously assumed one-compartment distribution of the response variable and simple first-order loss (kout) of R. These mode
Publikováno v:
Journal of pharmacokinetics and biopharmaceutics. 27(6)
A physiologic pharmacodynamic model was developed to jointly characterize the effects of corticosteroid treatment on adrenal suppression and T-helper cell trafficking during single and multiple dosing in asthmatic patients. Methylprednisolone (MP), c
Publikováno v:
Journal of pharmacokinetics and biopharmaceutics. 27(5)
Basic indirect pharmacodynamic models for agents which alter the generation of natural cells based on a life-span concept are introduced. It is assumed that cells (R) are produced at a constant rate (kin), survive for a specific duration TR, and then
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 292(2)
The pharmacokinetics and pharmacodynamics (PK/PD) of a humanized anti-Factor IX IgG1 monoclonal antibody (SB 249417, FIX mAb) were studied in Cynomolgus monkeys. Single i.v. bolus doses of 1, 3, or 10 mg/kg of FIX mAb were administered. The total FIX
Autor:
A A, Fasanmade, W J, Jusko
Publikováno v:
Biopharmaceuticsdrug disposition. 20(5)
Glucocorticoids have diverse effects on various components of the immune system and assessment of such activities in vivo often involves complex techniques and numerous animals. We developed a whole blood technique for determining proliferation rate
Publikováno v:
Journal of pharmacokinetics and biopharmaceutics. 27(1)
Prednisolone (Pred) and sirolimus (SIR) are immunosuppressive compounds acting through different mechanisms with moderate synergism found in vitro. Both drugs are metabolized partly by CYP3A enzymes. After i.v. administration of placebo, Pred (5 mg/k